Evidence map›Paper›PMID 39907377›Full record

ArticleArquivos brasileiros de cardiologia2025

Association between Estimated Small Dense Low-Density Lipoprotein-cholesterol (sdLDL-C) and Atherosclerotic Cardiovascular Disease Risk.

Shutang Zhang, Jinjie Du, Peng Wang, Min Lei, Canye Zhong, Yang Ou, Zhen Sun

Abstract read
In one paragraph

Article in Arquivos brasileiros de cardiologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Identification of a peptide inhibitor disrupting the PCSK9-LDLR interactionJournal of enzyme inhibition and medicinal chemistry · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shutang ZhangChongqing University Fuling Hospital, Chongqing Clinical Research Center for Geriatric Diseases - Geriatrics, Chongqing - China.
Jinjie DuChongqing University Fuling Hospital, Chongqing Clinical Research Center for Geriatric Diseases - Geriatrics, Chongqing - China.
Peng WangChongqing University Fuling Hospital, Chongqing Clinical Research Center for Geriatric Diseases - Geriatrics, Chongqing - China.
Min LeiChongqing University Fuling Hospital, Chongqing Clinical Research Center for Geriatric Diseases - Geriatrics, Chongqing - China.
Canye ZhongChongqing University Fuling Hospital, Chongqing Clinical Research Center for Geriatric Diseases - Geriatrics, Chongqing - China.
Yang OuChongqing University Fuling Hospital, Chongqing Clinical Research Center for Geriatric Diseases - Geriatrics, Chongqing - China.
Zhen SunChongqing University Fuling Hospital, Chongqing Clinical Research Center for Geriatric Diseases - Geriatrics, Chongqing - China.ORCID 0009-0004-9382-0389

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA new formula for estimating small, dense, low-density lipoprotein cholesterol (sdLDL-C) based on the results of the standard lipid panel is proposed.

objectivesTo assess the association between estimated sdLDL-C (EsdLDL-C) and atherosclerotic cardiovascular disease (ASCVD) risk.

methodsA total of 12,192 participants from the Korea National Health and Nutrition Examination Survey (KNHANES) database between 2010 and 2020 were included in this cross-sectional study. EsdLDL-C was calculated as EsdLDL-C= LDL-C - [1.43 × LDL-C - (0.14 × (ln (TG) × LDL-C)) - 8.99]. Logistic regression analyses were utilized to assess the association between EsdLDL-C and ASCVD risk. Subgroup analyses were performed based on age, body mass index (BMI), hypertension, and diabetes. An odds ratio (OR) with a 95% confidence interval (CI) was used for evaluation. P<0.05 was considered statistically significant.

resultsAmong 12,192 participants, 1,239 (10.16%) had ASCVD. The mean sdLDL-C of participants was estimated to be 42.43±14.75 mg/dL using the formula. Elevated EsdLDL-C levels (OR=1.33; 95%CI, 1.06-1.66) were associated with an increased risk of ASCVD. Subgroup analyses found that there may be an interaction between EsdLDL-C (Pinteraction= 0.001) or non-HDL-C (Pinteraction= 0.015) and hypertension on ASCVD risk.

conclusionsElevated estimated sdLDL-C levels were associated with the risk of ASCVD, and estimated sdLDL-C might be an alternative to sdLDL-C measurement for ASCVD risk assessment.

Indexed as

AtherosclerosisCardiovascular DiseasesCholesterol, LDLAdultAgedBiomarkersBody Mass IndexCross-Sectional StudiesFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedNutrition SurveysRepublic of KoreaRisk AssessmentBiomarkersCholesterol, LDL

Identifiers

PMID39907377
PMCPMC11805573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.